Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
NRC Health Common Stock
NRC
$471M
| $13.6M | 0.02% |
365,284
-27,800
| -7% | -$1.08M |
|
927
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.12B
| $13.5M | 0.02% |
+263,507
| New | +$13.4M |
|
928
Murphy Oil
MUR
$5.06B
| $13.5M | 0.02% |
314,500
-4,600
| -1% | -$207K |
|
929
MasTec
MTZ
$22.6B
| $13.5M | 0.02% |
+158,323
| New | +$13M |
|
|
LSI
930
DELISTED
Life Storage, Inc.
LSI
| $13.5M | 0.02% |
137,000
+34,800
| +34% | +$3.65M |
|
|
MFA
931
MFA Financial
MFA
$925M
| $13.5M | 0.02% |
1,368,425
+60,100
| +5% | +$604K |
|
932
Bentley Systems
BSY
$10.8B
| $13.4M | 0.02% |
363,000
+54,700
| +18% | +$1.98M |
|
933
Revolve Group
RVLV
$1.69B
| $13.4M | 0.02% |
602,108
-1,202,392
| -67% | -$28.9M |
|
|
BELFB
934
Bel Fuse Inc Class B
BELFB
$4.25B
| $13.3M | 0.02% |
404,651
-47,900
| -11% | -$1.56M |
|
935
Village Super Market
VLGEA
$627M
| $13.3M | 0.02% |
571,884
-41,000
| -7% | -$910K |
|
|
NXRT
936
NexPoint Residential Trust
NXRT
$631M
| $13.3M | 0.02% |
305,423
-74,890
| -20% | -$3.35M |
|
937
Gerdau
GGB
$9.48B
| $13.3M | 0.02% |
3,019,467
-198,951
| -6% | -$856K |
|
938
ZTO Express
ZTO
$17.6B
| $13.2M | 0.02% |
492,700
+42,800
| +10% | +$984K |
|
939
Coty
COTY
$2.43B
| $13.2M | 0.02% |
1,546,130
+140,000
| +10% | +$1.03M |
|
940
Coca-Cola Consolidated
COKE
$12.6B
| $13.2M | 0.02% |
258,190
+39,920
| +18% | +$1.91M |
|
941
MSCI
MSCI
$40.9B
| $13.2M | 0.02% |
28,421
+2,500
| +10% | +$1.16M |
|
|
CCRN
942
DELISTED
Cross Country Healthcare
CCRN
| $13.2M | 0.02% |
496,918
+427,900
| +620% | +$14M |
|
943
Tidewater
TDW
$4.56B
| $13.2M | 0.02% |
357,083
+194,383
| +119% | +$5.91M |
|
944
HUB Group
HUBG
$2.46B
| $13.2M | 0.02% |
331,072
+101,600
| +44% | +$3.97M |
|
945
Intercontinental Exchange
ICE
$85B
| $13.2M | 0.02% |
128,190
-786,600
| -86% | -$78.3M |
|
|
HDSN
946
Hudson Technologies
HDSN
$239M
| $13.1M | 0.02% |
1,297,948
+193,598
| +18% | +$1.89M |
|
|
POSH
947
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $13.1M | 0.02% |
732,000
-481,900
| -40% | -$8.56M |
|
948
Douglas Emmett
DEI
$1.95B
| $13.1M | 0.02% |
834,400
+498,100
| +148% | +$8.29M |
|
949
Kraft Heinz
KHC
$29.1B
| $13.1M | 0.02% |
321,181
-399,819
| -55% | -$15.2M |
|
950
Piper Sandler
PIPR
$5.34B
| $13M | 0.02% |
400,780
-64,400
| -14% | -$2.1M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.